Europe Androgenetic Alopecia Market Size & Outlook
Europe androgenetic alopecia market, 2018-2030 (US$M)
Related Markets
Europe androgenetic alopecia market highlights
- The Europe androgenetic alopecia market generated a revenue of USD 785.1 million in 2023.
- The market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating treatment in 2023.
- Devices is the most lucrative treatment segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 785.1 million |
| Market revenue in 2030 | USD 1,405.8 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals, Devices |
| Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.9% of the global androgenetic alopecia market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,493.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Androgenetic Alopecia Market Scope
Androgenetic Alopecia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe androgenetic alopecia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to androgenetic alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.59% in 2023. Horizon Databook has segmented the Europe androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, Europe held the second-largest share in the global androgenetic alopecia market. AGA is the most common hair loss disease in Europe, and it affects around 80% of men and 40% to 70% of women of Caucasian race of age 70 years & older.
Moreover, the rising healthcare expenditure, supported by developed healthcare facilities, is driving market growth in Europe. The European Hair Research Society, a nonprofit organization, plays an important role in conducting research related to reducing hair loss and preventive measures.
However, the growing trend of hair restoration using surgical methods may restrain market growth. According to a report by the International Society of Hair Restoration Surgery (ISHRS), Europe reported lucrative growth by the use of surgical hair restoration procedures in 2021, with 112,742, which is around a 5% increase from 2019.
Reasons to subscribe to Europe androgenetic alopecia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe androgenetic alopecia market databook
-
Our clientele includes a mix of androgenetic alopecia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe androgenetic alopecia market , including forecasts for subscribers. This continent databook contains high-level insights into Europe androgenetic alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe androgenetic alopecia market size, by country, 2018-2030 (US$M)
Europe Androgenetic Alopecia Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
